Cargando…

Sufentanil sublingual tablet system (Zalviso(®)) as an effective analgesic option after thoracic surgery: An observational study

INTRODUCTION: Sufentanil sublingual tablet system (SSTS) (Zalviso(®)) is a sublingual system for patient controlled analgesia, demonstrated to be an effective strategy for pain control after major abdominal and orthopedic surgery. We present a prospective observational study on the use of SSTS for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabio, Costa, Giuseppe, Pascarella, Chiara, Piliego, Antongiulio, Valenzano, Enrico, Di Sabatino, Filippo, Riccone, Federica, Bruno, Eugenio, Agro’ F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625280/ https://www.ncbi.nlm.nih.gov/pubmed/31333367 http://dx.doi.org/10.4103/sja.SJA_109_19

Ejemplares similares

Erratum: Sufentanil sublingual tablet system (Zalviso®) as an effective analgesic option after thoracic surgery: An observational study
Publicado: (2020)

Sublingual Sufentanil Tablet System (SSTS-Zalviso(®)) for Postoperative Analgesia after Orthopedic Surgery: A Retrospective Study
por: Angelini, Andrea, et al.
Publicado: (2022)

Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
por: Scardino, Marco, et al.
Publicado: (2018)

Sublingual sufentanil (Zalviso) patient-controlled analgesia after total knee arthroplasty: a retrospective comparison with oxycodone with or without dexamethasone
por: van Veen, David E, et al.
Publicado: (2018)

A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
por: Koushik, Sarang S., et al.
Publicado: (2022)

Between evidence and commerce – the case of sufentanil sublingual tablet systems
por: Bantel, C., et al.
Publicado: (2017)

Neuromuscular blockade: The importance of T.O.F. (Think outside the frame!)
por: Agrò, Felice Eugenio, et al.
Publicado: (2019)

An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain
por: Hutchins, Jacob L, et al.
Publicado: (2018)

Sufentanil Sublingual Tablet Reduces Postoperative Opioid Use Following Outpatient Plastic Surgery
por: Seify, Hisham
Publicado: (2022)

Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
por: Seify, Hisham
Publicado: (2022)

Commentary on: Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
por: Kislevitz, Mikaela L, et al.
Publicado: (2022)

Abstract: Safety and Efficacy of Sufentanil Sublingual 30 mcg Tablets for the Treatment of Acute Pain following Outpatient Abdominoplasty
por: Lakshman, Shankar, et al.
Publicado: (2016)

Sufentanil sublingual tablet system for enhanced recovery after total knee arthroplasty: a prospective observational case study
por: Rineau, Emmanuel, et al.
Publicado: (2022)

Sublingual sufentanil for postoperative pain relief: first clinical experiences
por: Meijer, Fleur, et al.
Publicado: (2018)

Sufentanil Sublingual Tablet System for the Management of Postoperative Pain Following Open Abdominal Surgery: A Randomized, Placebo-Controlled Study
por: Ringold, Forrest G., et al.
Publicado: (2015)

Erector spinae plane block growing potential: Pain management in laparoscopy nephrectomy
por: Piliego, Chiara, et al.
Publicado: (2020)

Patient and Healthcare Professional Satisfaction Ratings and Safety Profile of Sufentanil Sublingual Tablets for Treatment of Acute Pain: A Pooled Demographic Analysis
por: Leiman, David, et al.
Publicado: (2021)

Sufentanil Sublingual Tablet System vs. Intravenous Patient-Controlled Analgesia with Morphine: Postoperative Pain Control and Its Impact in Quality of Recovery
por: Fernandes, Diana L, et al.
Publicado: (2023)

Sufentanil Sublingual Tablet System vs. Intravenous Patient-Controlled Analgesia with Morphine for Postoperative Pain Control: A Randomized, Active-Comparator Trial
por: Melson, Timothy I, et al.
Publicado: (2014)

Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study
por: Turi, Stefano, et al.
Publicado: (2019)

Not just a matter of weight: A case report of ECMO treatment in a severely obese patient
por: Schiavoni, L., et al.
Publicado: (2022)

Preparation and evaluation of sublingual tablets of zolmitriptan
por: Prajapati, Shailesh T, et al.
Publicado: (2014)

Selective spinal anesthesia with hyperbaric prilocaine provides better perioperative pain control than local anesthesia for ambulatory inguinal hernia repair without affecting discharging time: a randomized controlled trial
por: Costa, Fabio, et al.
Publicado: (2022)

Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017)

The Preparation and Evaluation of Cyanocobalamin Mucoadhesive Sublingual Tablets
por: Ma’ali, Anwar, et al.
Publicado: (2023)

Sublingual Sufentanil versus Standard-of-Care (Patient-Controlled Analgesia with Epidural Ropivacaine/Sufentanil or Intravenous Morphine) for Postoperative Pain Following Pancreatoduodenectomy: A Randomized Trial
por: Groen, Jesse Vincent, et al.
Publicado: (2022)

Sufentanil sublingual tablet system versus oral oxycodone for management of postoperative pain in enhanced recovery after surgery pathway for total knee arthroplasty: a randomized controlled study
por: Noel, Emmanuel, et al.
Publicado: (2020)

The statistical analyses of the study “Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study”[Letter]
por: Wang, Xiaohan, et al.
Publicado: (2019)

The Statistical Analyses Of The Study “Sufentanil Sublingual Tablet System (SSTS) For The Management Of Postoperative Pain After Major Abdominal And Gynecological Surgery Within An ERAS Protocol: An Observational Study” [Response To Letter]
por: Turi, Stefano, et al.
Publicado: (2019)

Formulation and evaluation of sublingual tablets containing Sumatriptan succinate
por: Prajapati, Shailesh T, et al.
Publicado: (2012)

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
por: Quirt, J., et al.
Publicado: (2018)

Interaction of Analgesic Effects of Dezocine and Sufentanil for Relief of Postoperative Pain: A Pilot Study
por: Zhu, He, et al.
Publicado: (2020)

A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
por: Blaiss, Michael, et al.
Publicado: (2023)

Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
por: Gunderson, Erik W., et al.
Publicado: (2016)

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets
por: Kawajiri, Masakazu, et al.
Publicado: (2019)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022)

Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness
por: Alyami, Hamad S, et al.
Publicado: (2021)

Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer‐masked, controlled trial
por: Pascarella, G., et al.
Publicado: (2021)

Sublingual Sufentanil vs. Intravenous Fentanyl for the Treatment of Acute Postoperative Pain in the Ambulatory Surgery Center: A Randomized Clinical Trial
por: Berg, Aaron, et al.
Publicado: (2022)

Sufentanil Sublingual for Acute Post-Operative Pain: A Systematic Literature Review Focused on Pain Intensity, Adverse Events, and Patient Satisfaction
por: Giaccari, Luca G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0o5lopacllsjm7kj7e31t3latk